Χώρα: Ιρλανδία
Γλώσσα: Αγγλικά
Πηγή: HPRA (Health Products Regulatory Authority)
Colestyramine resin
CHEPLAPHARM Arzneimittel GmbH
C10AC; C10AC01
Colestyramine resin
4 g/sachet
Powder for oral suspension
Bile acid sequestrants; colestyramine
Marketed
1979-04-01
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT QUESTRAN™ 4 G/SACHET POWDER FOR ORAL SUSPENSION, COLESTYRAMINE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. WHAT QUESTRAN IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE QUESTRAN 3. HOW TO TAKE QUESTRAN 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE QUESTRAN 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT QUESTRAN IS AND WHAT IT IS USED FOR Questran contains the active substance colestyramine. Each sachet of Questran contains 4 g of colestyramine. Colestyramine belongs to a group of medicines called bile acid binding resins. Questran is used to lower your body’s level of cholesterol (a type of fat) which can cause heart disease. This medicine works in the digestive system and absorbs the cholesterol‐containing bile acids, which then pass out through the body in the faeces. Questran may also be used to help stop some types of diarrhoea or itching. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE QUESTRAN DO NOT TAKE QUESTRAN IF YOU: • are ALLERGIC to colestyramine or any of the other ingredients of this medicine (listed in section 6). • have an illness which results in your BILE DUCT BEING COMPLETELY BLOCKED (e.g. gall stones). Check with your doctor if you are unsure. CHILDREN This medicine is NOT SUITABLE for children UNDER 6 YEARS of age. WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking Questran if you are concerned about any of the following: Long‐term treatment with high doses of Questran may r Διαβάστε το πλήρες έγγραφο
Health Products Regulatory Authority 02 March 2023 CRN00CY2Z Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Questran 4g/sachet, Powder for oral suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet contains 4 g of colestyramine. Excipient(s) with known effect: Each sachet contains 3.79 g sucrose (421 mg of sucrose per gram of powder), and 97.5 mg propylene glycol (as alginate). For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Powder for oral suspension. A fine, homogeneous, cream to buff-coloured powder for oral suspension. On reconstitution with 150 ml of water or fruit juice a uniform suspension is formed. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS 1. A basic anion exchange resin to complex bile acids and reduce plasma levels of cholesterol. 2. Reduction of plasma cholesterol in hypercholesterolaemia, particularly in those patients who have been diagnosed as Fredrickson’s Type II (high plasma cholesterol with normal or slightly elevated triglycerides). 3. Relief of pruritus associated with partial biliary obstruction and primary biliary cirrhosis. 4. Relief of diarrhoea associated with ileal reaction, Crohn’s disease, vagotomy and diabetic vagal neuropathy. 5. Management of radiation-induced diarrhoea. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults (including the elderly)_: 1. Hypercholesterolaemia The usual total daily dose is 12 to 24 g (the contents of 3 to 6 sachets) in single or up to 4 divided doses. The maximum daily intake should not exceed 36 g (contents of 9 sachets). 2. Management of diarrhoea The usual daily dose is 12 to 24 g (the contents of 3 to 6 sachets) in single or up to 4 divided doses. The maximum daily intake should not exceed 36 g (contents of 9 sachets). In all patients presenting with diarrhoea induced by bile acid malabsorption, if a response is not seen within 3 days, then alternative therapy should be initiated. 3. Pruritus The usual daily dose is 4 to 8 g (contents of 1 to 2 sachets). Doses of Διαβάστε το πλήρες έγγραφο